GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (XTER:ILU) » Definitions » Interest Expense

Illumina (XTER:ILU) Interest Expense : €-84 Mil (TTM As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Illumina Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Illumina's interest expense for the three months ended in Sep. 2024 was € -32 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was €-84 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Illumina's Operating Income for the three months ended in Sep. 2024 was € 228 Mil. Illumina's Interest Expense for the three months ended in Sep. 2024 was € -32 Mil. Illumina's Interest Coverage for the quarter that ended in Sep. 2024 was 7.03. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Illumina Interest Expense Historical Data

The historical data trend for Illumina's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Interest Expense Chart

Illumina Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -46.80 -40.28 -53.99 -24.54 -70.61

Illumina Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.80 -16.51 -16.56 -18.58 -32.44

Illumina Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Illumina  (XTER:ILU) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Illumina's Interest Expense for the three months ended in Sep. 2024 was €-32 Mil. Its Operating Income for the three months ended in Sep. 2024 was €228 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was €2,344 Mil.

Illumina's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Sep. 2024 )/Interest Expense (Q: Sep. 2024 )
=-1*227.953/-32.436
=7.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Illumina Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (XTER:ILU) » Definitions » Interest Expense
Comparable Companies
NTRA WAT LH ICLR DGX MTD RVTY EXAS MEDP QGEN TMO DHR XSWX:LONN A IQV IDXX SHSE:603259 XPAR:BIM XPAR:ERF CRL
Traded in Other Exchanges
ILMN:USA ILMN:Mexico 1ILMN:Italy 0J8Z:UK ILU:Germany ILU:Germany I1LM34:Brazil ILMN:Austria
Address
5200 Illumina Way, San Diego, CA, USA, 92122
Website
https://www.illumina.com
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina Headlines

No Headlines